Last reviewed · How we verify

Magnesium Sulfate, Heptahydrate

University of Utah · FDA-approved active Small molecule

Magnesium Sulfate, Heptahydrate is a Electrolyte supplement / anticonvulsant / bronchodilator Small molecule drug developed by University of Utah. It is currently FDA-approved for Seizure prophylaxis in pre-eclampsia and eclampsia, Acute asthma exacerbation (IV bronchodilator), Cardiac arrhythmias (torsades de pointes). Also known as: Intravenous magnesium sulfate.

Magnesium sulfate acts as a physiological calcium antagonist and NMDA receptor antagonist, reducing neuronal excitability and smooth muscle contractility.

Magnesium sulfate acts as a physiological calcium antagonist and NMDA receptor antagonist, reducing neuronal excitability and smooth muscle contractility. Used for Seizure prophylaxis in pre-eclampsia and eclampsia, Acute asthma exacerbation (IV bronchodilator), Cardiac arrhythmias (torsades de pointes).

At a glance

Generic nameMagnesium Sulfate, Heptahydrate
Also known asIntravenous magnesium sulfate
SponsorUniversity of Utah
Drug classElectrolyte supplement / anticonvulsant / bronchodilator
TargetNMDA receptor, voltage-gated calcium channels
ModalitySmall molecule
Therapeutic areaObstetrics, Neurology, Cardiology, Pulmonology
PhaseFDA-approved

Mechanism of action

Magnesium ions compete with calcium for entry into cells and block NMDA-type glutamate receptors, thereby reducing excitatory neurotransmission. This mechanism underlies its use in preventing seizures (particularly eclampsia/pre-eclampsia), treating cardiac arrhythmias, and providing bronchodilation in acute asthma. The heptahydrate form is the standard pharmaceutical salt used for parenteral and oral administration.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Magnesium Sulfate, Heptahydrate

What is Magnesium Sulfate, Heptahydrate?

Magnesium Sulfate, Heptahydrate is a Electrolyte supplement / anticonvulsant / bronchodilator drug developed by University of Utah, indicated for Seizure prophylaxis in pre-eclampsia and eclampsia, Acute asthma exacerbation (IV bronchodilator), Cardiac arrhythmias (torsades de pointes).

How does Magnesium Sulfate, Heptahydrate work?

Magnesium sulfate acts as a physiological calcium antagonist and NMDA receptor antagonist, reducing neuronal excitability and smooth muscle contractility.

What is Magnesium Sulfate, Heptahydrate used for?

Magnesium Sulfate, Heptahydrate is indicated for Seizure prophylaxis in pre-eclampsia and eclampsia, Acute asthma exacerbation (IV bronchodilator), Cardiac arrhythmias (torsades de pointes), Magnesium deficiency / hypomagnesemia, Constipation (oral laxative).

Who makes Magnesium Sulfate, Heptahydrate?

Magnesium Sulfate, Heptahydrate is developed and marketed by University of Utah (see full University of Utah pipeline at /company/university-of-utah).

Is Magnesium Sulfate, Heptahydrate also known as anything else?

Magnesium Sulfate, Heptahydrate is also known as Intravenous magnesium sulfate.

What drug class is Magnesium Sulfate, Heptahydrate in?

Magnesium Sulfate, Heptahydrate belongs to the Electrolyte supplement / anticonvulsant / bronchodilator class. See all Electrolyte supplement / anticonvulsant / bronchodilator drugs at /class/electrolyte-supplement-anticonvulsant-bronchodilator.

What development phase is Magnesium Sulfate, Heptahydrate in?

Magnesium Sulfate, Heptahydrate is FDA-approved (marketed).

What are the side effects of Magnesium Sulfate, Heptahydrate?

Common side effects of Magnesium Sulfate, Heptahydrate include Flushing, Sweating, Hypotension, Depressed reflexes, Muscle weakness, Respiratory depression (at high doses).

What does Magnesium Sulfate, Heptahydrate target?

Magnesium Sulfate, Heptahydrate targets NMDA receptor, voltage-gated calcium channels and is a Electrolyte supplement / anticonvulsant / bronchodilator.

Related